Press release
Plantar Fasciitis Pipeline Analysis, Clinical Trials, 2025 | Plantar Fasciitis Treatment Market by DelveInsight | Mimedx, Revance Therapeutics
Plantar Fasciitis Pipeline Insights, 2025
Plantar Fasciitis Disease Overview:
Plantar fasciitis is one of the most common reasons for heel pain. The plantar fascia is a thick, web-like ligament that links the heel bone to the front of the foot. It plays a crucial role in walking by acting as a shock absorber and supporting the foot's arch. Over time, daily activities can cause significant strain on this ligament, leading to inflammation, which results in heel pain and stiffness.
Download our report @ https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight [https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
"Plantar Fasciitis Pipeline Insight 2025 [https://www.delveinsight.com/sample-request/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Plantar Fasciitis Therapeutics Market.
Key Takeaways from the Plantar Fasciitis Pipeline Report
*
DelveInsight's Plantar Fasciitis pipeline report depicts a robust space with 3+ active players working to develop 3+ pipeline therapies for Plantar Fasciitis treatment.
*
The FDA expanded ActiPatch Registered 's OTC clearance to encompass general musculoskeletal pain, broadening its application beyond specific conditions.
*
The FDA granted 510(k) clearance for Erchonia's FX 635 low-level laser device for the temporary relief of chronic musculoskeletal pain. This clearance was based on clinical trials demonstrating significant pain reduction in patients.
*
Key Plantar Fasciitis companies such as Mimedx, Revance Therapeutics, and others are evaluating new drugs for Plantar Fasciitis to improve the treatment landscape.
*
Promising Plantar Fasciitis therapies are Micronized dHCAM, DAXI, and others.
Plantar Fasciitis Pipeline Analysis
The Plantar Fasciitis pipeline insights report 2025, provides insights into:
*
Provides comprehensive insights into key companies developing therapies in the Plantar Fasciitis Market.
*
Categorizes Plantar Fasciitis therapeutic companies by development stage: early, mid, and late-stage.
*
Highlights major companies involved in targeted therapy development, including both active and inactive (paused/discontinued) projects.
*
Reviews emerging Plantar Fasciitis drugs under development based on:
*
Stage of development
*
Plantar Fasciitis Route of administration
*
Target receptor
*
Monotherapy vs. combination therapy
*
Plantar Fasciitis Mechanism of action
*
Molecular type
*
Offers detailed analysis of:
*
Company-to-company and company-academia collaborations
*
Plantar Fasciitis Licensing agreements
*
Funding and investment activities supporting future Plantar Fasciitis market advancement.
Request for a sample report @ https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight [https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Plantar Fasciitis Emerging Drugs
*
Micronized dHCAM: Mimedx
*
DAXI: Revance Therpaeutics
Plantar Fasciitis Companies
Around three major companies are currently developing therapies for Plantar Fasciitis. Among them, Mimedx and a few others have drug candidates in the mid to late stages of development, specifically in Phase II and Phase III clinical trials.
DelveInsight's report covers around 140+ products under different phases of Plantar Fasciitis clinical trials [https://www.delveinsight.com/sample-request/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] like
*
Plantar Fasciitis Late stage Therapies (Phase III)
*
Plantar Fasciitis Mid-stage Therapies (Phase II)
*
Plantar Fasciitis Early-stage Therapies (Phase I)
*
Plantar Fasciitis Pre-clinical and Plantar Fasciitis Discovery stage Therapies
*
Plantar Fasciitis Discontinued & Inactive Therapies
Plantar Fasciitis pipeline report provides the Plantar Fasciitis therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Plantar Fasciitis Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Plantar Fasciitis Therapies and Key Plantar Fasciitis Companies: Plantar Fasciitis Clinical Trials and recent advancements [https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Plantar Fasciitis Pipeline Therapeutic Assessment
- Plantar Fasciitis Assessment by Product Type
- Plantar Fasciitis By Stage
- Plantar Fasciitis Assessment by Route of Administration
- Plantar Fasciitis Assessment by Molecule Type
Table of Content
1. Report Introduction
2. Executive Summary
3. Plantar Fasciitis Current Treatment Patterns
4. Plantar Fasciitis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Plantar Fasciitis Late-Stage Products (Phase-III)
7. Plantar Fasciitis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Plantar Fasciitis Discontinued Products
13. Plantar Fasciitis Product Profiles
14. Plantar Fasciitis Key Companies
15. Plantar Fasciitis Key Products
16. Dormant and Discontinued Products
17. Plantar Fasciitis Unmet Needs
18. Plantar Fasciitis Future Perspectives
19. Plantar Fasciitis Analyst Review
20. Appendix
21. Report Methodology
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=plantar-fasciitis-pipeline-analysis-clinical-trials-2025-plantar-fasciitis-treatment-market-by-delveinsight-mimedx-revance-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Plantar Fasciitis Pipeline Analysis, Clinical Trials, 2025 | Plantar Fasciitis Treatment Market by DelveInsight | Mimedx, Revance Therapeutics here
News-ID: 3991381 • Views: …
More Releases from ABNewswire
Hillman Unveils New-Generation Hunting Boots for Men Featuring Dual-Insulation a …
Image: https://www.abnewswire.com/upload/2025/09/ba5edccf338bc4d7305201efbc60a77a.jpg
Hillman, the performance hunting brand trusted by professionals across rugged North American terrain, today announced the release of its next-generation line of hunting boots for men [https://hillmangear.com/collections/hunting-boots-men-s-hunt-footwear], engineered with a dual-insulation system inspired by space technology. The new hunting boots collection features NASA-developed Aerogel Trademark paired with Matrix Registered insulation to deliver arctic-level warmth at a fraction of the weight and bulk of traditional padded boots.
Purpose-built for early season…
Cedric D. Fisher & Company Publishers Releases SIGHT: Groundbreaking Novel Explo …
Cedric D. Fisher & Company Publishers launches SIGHT by Alexandria Clarimond, a literary fiction novel following Elora ("Ellie") through seven decades of life as she confronts progressive blindness from macular degeneration. The novel's innovative "Seven Sight Loss Events" structure parallels physical vision decline with spiritual awakening, creating a powerful meditation on resilience and meaning.
SAN ANTONIO, TX - September 18th, 2025 - Cedric D. Fisher & Company Publishers, a San Antonio-based…
New Launch Protech Systems - A Security System Installation Company in Vancouver …
Protech Systems, a newly launched security system installation company in Vancouver, BC, is now open to serve homeowners and businesses. The company specializes in installing and integrating advanced security solutions, including alarm systems, security cameras, smart home integrations, and monitoring services.
Vancouver, BC - Protech Systems has officially launched in Vancouver, British Columbia, bringing modern home and commercial security solutions to families and business owners across the Lower Mainland. With over…
Soft Tissue Sarcoma Market to Experience Notable Growth in Forecast Span by 2034 …
The Key Soft Tissue Sarcoma Companies in the market include - Epizyme, Blueprint Medicines, Eli Lilly, Philogen, Intensity Therapeutics, Peel Therapeutics, Pure Biologics, Edgewood Oncology, Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Apexigen, Lytix Biopharma, Incyte Corporation, Iovance Biotherapeutics, Aadi Bioscience, and others.
The Soft Tissue Sarcoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period.…
More Releases for Plantar
Top Trends Transforming the Plantar Fasciitis Treatment Market Landscape in 2025 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Plantar Fasciitis Treatment Industry Market Size Be by 2025?
In the past few years, the market size for treatments of plantar fasciitis has experienced substantial growth, set to increase from $1.68 billion in 2024 to $2.08 billion in 2025 with a CAGR of 24.0%. This incredible expansion during the historical period…
Plantar Plate Repair Market: Global Industry Analysis and Forecast
The global plantar plate repair market was valued at approximately USD 325 million in 2023 and is anticipated to reach USD 510 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
The plantar plate repair market has gained significant momentum in recent years due to a rising prevalence of foot deformities, increased awareness of foot health, and advancements in minimally invasive surgical procedures. The plantar plate, a…
Emerging Trends Influencing The Growth Of The Plantar Fasciitis Treatment Market …
The Plantar Fasciitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Plantar Fasciitis Treatment Market?
In recent times, the market size for treating plantar fasciitis has seen an explosive growth. Its value is projected to increase from $1.68…
Plantar Fasciitis Treatment Market Outlook 2024-2030
Plantar fasciitis, a common ailment among runners, hikers, and individuals with active lifestyles, as well as those who spend long hours on their feet, presents a significant market opportunity for treatment providers. With the Plantar Fasciitis Treatment Market poised to reach a valuation of US$ 1190 Mn. at a CAGR of 4.40% during the forecast period, let's unravel the dynamics shaping this burgeoning sector:
Know More About The Report:
https://www.maximizemarketresearch.com/market-report/global-plantar-fasciitis-treatment-market/110197/
Market Dynamics:
The…
Plantar Fasciitis Market Research Survey Report, 2021-2028
Plantar Fasciitis Market Report 2022: Industry aims to provide an overview of the industry through detailed market segmentation. The report offers thorough information about the overview and scope of the market along with its drivers, restraints, and trends. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study.
Get a Sample PDF of the Report @ https://impeccablemarketresearch.com/enquiry/request-sample-pdf/15701229?utm_source=Openpr&utm_medium=Shubhamko
…
Plantar Fasciitis Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Plantar Fasciitis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Plantar Fasciitis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plantar Fasciitis Treatment with respect…
